Draft Guidance for Industry and FDA Staff Whole

Tags

food and drug administration, FDA, FDA documents, FDA reports, FDA approval, FDA regulations, FDA recall, food safety, FDA news, department of public safety

You must be logged in to download this document

be first to review

FDADocs

Draft Guidance for Industry and FDA Staff: Whole Grains Label ~'taternents Docket No. 2006D-0066 References for Draft Guidance Tab I- 1 . U.S . Department of IJealtlh and Human Services and U .S . Department of Agriculture, "Dietary Guidelines for Americans, 2005q'° _I aAVW .b ea lt,hierus .-c>v/c~Yt,tar i.deli ncs, 2005 . Tab J - 2 . 1-loseney, R. Carl, "Corn," "Principles of Cereal Science and Teclinology,,> St. Paul, NIN, 1986 . Referen ce s for Noti ce of Availability Tab I - L. U.S . Department of I-Iealth and Hurslan Services and U .S . Department of Agriculture, "Dietary Gaidelines for Americans, 2005," N;~'~~wtiv .healthiel-iIs .(Yoy/iiictarygiti,delines, ZOOS .

Public Domain

downloads:0

rating:not rated

reviews:0

posted:5/9/2008

language:English

search termpage on Googletimes searched

FDA and Industry Actions on Premarket Approval Applications PMAs Effect on FDA Review Clock and Performance Assessment Guidance for Industry and FDA Staff

shared by:GovernmentDocs on:5/4/2008 | views:59 | downloads:0 | comments:0 | category:legal

Draft Guidance for Industry and FDA Staff Whole

FDA A fillable

Draft Guidance for Industry and FDA Staff Whole

Draft Guidance for Industry and FDA Staff Establishing

FDA Assistance to Industry

Addendum to FDA Guidance for Industry

Compliance Policy Guide Guidance for FDA Staff Sec

FDA CONSOLIDATED CITIZEN PETITION RESPONSE REFERENCE FDA draft

FDA and Industry Actions on Premarket Approval Applications PMAs Effect on FDA Review Clock and Performance Assessment Guidance for Industry and FDA Staff

FDA Regulatory Pathway Annual FDA and the Changing

Medical Device Tracking Guidance for Industry and FDA Staff

FDA Field Inspections

FDA Organizational Chart

FDA in the International Community

FDA s Accomplishments in 2005

AFFIDAVIT IN TRANSIT FDA

Pfizer DTC Hearing Abstract

ROTARIX Rotavirus Vaccine Live Oral

Section Pharmacological Research of VasoCleaner on Hyperlipidemia and Atherosclerosis

Section Documents regarding a Chinese Patent of the herbal formuIation

Section Toxicological tests of VasoCleaner in Mice and Rats

June Pre Market Notification Letter

Report on toxicity test of Xiwang capsule

August letter to Christopher Weisberg P A

Laboratoires Laphal DRD B P Allauch CEDEX France

Transmittal Letter and July letter to Christopher Weisberg P A